Edition:
United Kingdom

ZIOPHARM Oncology Inc (ZIOP.OQ)

ZIOP.OQ on NASDAQ Stock Exchange Capital Market

4.31USD
20 Apr 2018
Change (% chg)

$0.03 (+0.70%)
Prev Close
$4.28
Open
$4.25
Day's High
$4.37
Day's Low
$4.25
Volume
225,801
Avg. Vol
372,899
52-wk High
$7.88
52-wk Low
$3.33

Chart for

About

ZIOPHARM Oncology, Inc. is a biopharmaceutical company, which is seeking to develop, acquire and commercialize, on its own or with partners, a portfolio of cancer therapies that address unmet medical needs. The Company is focused on developing products in immuno-oncology that employ gene expression, control and cell technologies... (more)

Overall

Beta: 1.54
Market Cap(Mil.): $890.11
Shares Outstanding(Mil.): 141.96
Dividend: --
Yield (%): --

Financials

  ZIOP.OQ Industry Sector
P/E (TTM): -- 84.02 32.74
EPS (TTM): -0.50 -- --
ROI: -45.27 1.58 14.38
ROE: -- 2.41 16.07

BRIEF-Ziopharm Oncology Addresses Rumors And Stock Volatility, Affirms 2018 Guidance

* ZIOPHARM ONCOLOGY ADDRESSES RUMORS AND STOCK VOLATILITY, AFFIRMS 2018 GUIDANCE

06 Feb 2018

BRIEF-Ziopharm Oncology To Initiate Pivotal Trial Of Cancer Treatment in Second Half of 2018

* ZIOPHARM ONCOLOGY PROVIDES UPDATE ON STANDOUT TECHNOLOGIES DURING THE 36TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

09 Jan 2018

BRIEF-Ziopharm Oncology reports third quarter financial results

* Ziopharm Oncology reports third quarter 2017 financial results and provides update on recent activities

06 Nov 2017

Earnings vs. Estimates